muscle pharm corp (MSLP:OTC US)
muscle pharm corp (MSLP) Snapshot
|
Open
$11.72
|
Previous Close
$11.74
|
|
|
Day High
$11.80
|
Day Low
$11.65
|
|
|
52 Week High
07/11/12 - $17.43
|
52 Week Low
11/7/12 - $3.40
|
|
|
Market Cap
83.8M
|
Average Volume 10 Days
85.8K
|
|
|
EPS TTM
$-12.80
|
Shares Outstanding
7.1M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
muscle pharm corp (MSLP) Related Businessweek News
No Related Businessweek News Foundmuscle pharm corp (MSLP) Details
MusclePharm Corporation develops, manufactures, and markets sports nutrition products in the United States and internationally. It offers Amino 1, a hydration sports recovery drink; Armor-V Advanced Multi Nutrient Complex; Assault for enhancing focus and building lean muscle mass; Battle Fuel XT, an herbal formula to enhance athletic performance and support testosterone production; BCAA for muscle development and maintenance; and Bizzy Diet Stack, GetSwole Stack, and Live Shredded Stack, which support fat loss and lean muscle tissue. The company also provides MusclePharm BulletProof Nighttime Recovery Matrix that promotes deep sleep, optimizes recovery, and supports growth hormone/testosterone output; Carnitine Core, which provides energy for muscle gain and fat loss; Casein, a slow digesting protein; CLA Core that supports body composition and aid in weight loss; and Combat Powder, a high protein supplement. In addition, it offers Creatine that promotes strength, power, and endurance; MusclePharm Energel that provides energy for workouts and daily activities; Fish Oil, a blend of nutritional oils; and Glutamine to assist in recovery time and enhance muscle growth. Further, the company provides Hybrid N.O. to increase muscle fullness and vascularity; MusclePharm Musclegel, a protein and nutrition supplement; Re-Con that promotes post-workout growth and repair; MusclePharm Shred Matrix, a multi-level weight-loss system; and Z-Core PM, a mineral support formula. Additionally, it offers products for women, including FitMiss Burn for appetite balance, increased energy, and healthy metabolism women; FitMiss Cleanse and FitMiss Tone, which support body composition and weight management women; FitMiss Delight, a protein nutrition shake women; FitMiss Ignite, a pre-workout energy booster women; and FitMiss Balance, a multivitamin and mineral product. The company also licenses its apparel line. The company was founded in 2008 and is headquartered in Denver, Colorado.
muscle pharm corp (MSLP) Top Compensated Officers
muscle pharm corp (MSLP) Key Developments
Muscle Pharm Corp. Presents at 14th Annual B. Riley & Company Investor Conference, May-20-2013 01:00 PM. Venue: Loews Santa Monica Beach Hotel, 1700 Ocean Avenue, Santa Monica, CA 90401, United States. Speakers: John H. Bluher, Co-Chairman and Executive Vice President.
Muscle Pharm Corp. reported consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported net sales of $22,561,167 compared to $16,560,680 a year ago. Loss from operations was $401,908 compared to $476,272 a year ago. LBIDTA was $6,262,089 compared to $13,213,756 a year ago. Net loss was $7,361,981 or $1.78 per basic and diluted common share compared to $16,035,293 or $11.23 per basic and diluted common share a year ago. For first quarter, 2013, prior to accounting for non-cash, stock-based compensation consulting expense of approximately $3.6 million, the company reported its first quarterly positive adjusted operating income of $2.8 million. After taking effect for the $3.6 million consulting expense, the company recorded a net loss from operations of $721,000 as compared to $727,000 in first quarter 2012. The increase in Net Sales were attributable to the company's continuous marketing and promotional activities of its MusclePharm brand, new product introductions, an increase in sales and marketing personnel, and a sharp rise in international sales which increased in first quarter 2013 by 107% to $6.7 million, as compared to $3.3 million in first quarter 2012. The company remains on track to meet its previous guidance for gross revenue to exceed $100 million in 2013.
Muscle Pharm Corp. announced that they will report Q1, 2013 results After-Market on May 15, 2013
| Recently Viewed | |||
| MSLP:US | $11.80 USD | +0.06 |  |
| Company | Last | Change | |
| No competitor information is available for MSLP. | |||
| View Industry Companies | |||
Industry Analysis
MSLP
Industry Average
| Valuation | MSLP | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.7x |
|
| Price/Book | 11.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact MUSCLE PHARM CORP, please visit www.musclepharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
